← Back to Search

High-Fruit Diet for Type 2 Diabetes

N/A
Recruiting
Led By Courtney M. Peterson, Ph.D.
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
20-65 years old
20-65 years old
Timeline
Screening 2 days
Treatment 3 months
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test whether consuming a diet rich in whole fruit for 12 weeks can induce diabetes remission and improve blood sugar, liver fat, and cardiovascular health in adults with type 2 diabetes.

Who is the study for?
Adults aged 20-65 with type 2 diabetes, diagnosed in the last 6 years and having an HbA1c level of 6.0-9.5%, can join this trial if they have a BMI between 27.0-45.0 kg/m^2 and are not on insulin or weight loss medication, pregnant, or have significant health issues that could interfere with the study.Check my eligibility
What is being tested?
The trial is testing whether a high-fruit diet over a period of 12 weeks can help adults with type 2 diabetes improve their blood sugar control and possibly achieve diabetes remission while also looking at effects on liver fat and heart health.See study design
What are the potential side effects?
While specific side effects are not listed for eating whole fruit, potential concerns may include digestive changes due to increased fiber intake or unexpected impacts on blood sugar levels which will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 20 and 65 years old.
Select...
I am between 20 and 65 years old.

Timeline

Screening ~ 2 days
Treatment ~ 3 months
Follow Up ~3 months
This trial's timeline: 2 days for screening, 3 months for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
2-hour glucose tolerance
Beta-cell function
Diabetes medication usage
+11 more
Secondary outcome measures
Dosage of cardiovascular medications used
Fasting lipids
Heart rate
+3 more
Other outcome measures
Body weight
Caloric intake
Depression
+18 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: High-Fruit DietExperimental Treatment1 Intervention

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,589 Previous Clinical Trials
2,280,333 Total Patients Enrolled
Courtney M. Peterson, Ph.D.Principal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
144 Total Patients Enrolled

Media Library

High-Fruit Diet Clinical Trial Eligibility Overview. Trial Name: NCT03758742 — N/A
Type 2 Diabetes Research Study Groups: High-Fruit Diet
Type 2 Diabetes Clinical Trial 2023: High-Fruit Diet Highlights & Side Effects. Trial Name: NCT03758742 — N/A
High-Fruit Diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT03758742 — N/A
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT03758742 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would be the ideal candidates for this experiment?

"Eligibility for this trial requires a diagnosis of type 2 diabetes and an age range between 20 and 65. Approximately 21 applicants are being accepted into the study."

Answered by AI

Is there an age limit for individuals who can participate in this research?

"This clinical study welcomes individuals between the ages of 20 to 65. For those below 18 years old, there are 192 trials available and 1,067 for elderly patients above 65."

Answered by AI

Are there any available openings for enrollees in this clinical trial?

"Per the information posted on clinicaltrials.gov, this medical trial is seeking suitable applicants. It was initially made available to the public in September 2019 and its details were last amended in November 2022."

Answered by AI

What are the main aims of this investigation?

"Evaluating Beta-cell function will serve as the primary outcome of this trial, assessed through Change from baseline scores at Weeks 4 and 12 and Months 6, 9, and 12. Secondary outcomes include Fasting lipids (Total cholesterol/LDL Cholesterol/HDL Cholesterol/Triglycerides), Heart Rate (Beats per Minute) and Number of Cardiovascular Medications used."

Answered by AI

How many subjects are enrolled in this clinical experimentation?

"Affirmative. Per information on clinicaltrials.gov, this medical trial is actively in the recruitment phase. It was posted on September 10th 2019 and its last update was November 29th 2022 with a total of 21 patients needed from 1 site."

Answered by AI

Who else is applying?

What state do they live in?
Alabama
How old are they?
18 - 65
What site did they apply to?
Department of Nutrition Sciences, University of Alabamam at Birmingham
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2
3+
0

Why did patients apply to this trial?

My diabetes is out of control. I've tried everything and nothing works need help.
PatientReceived 1 prior treatment
I hope to learn more about diet effects on diabetes and hope to learn how to help control my diabetes.
PatientReceived 1 prior treatment
My neuropathy is getting worse and my daily glucose levels or increasing. My current medication is not working. I need professional help.
PatientReceived 2+ prior treatments
I have type 2 diabetes and am struggling to get my blood sugar under control. Hoping to get some help with proper nutrition for people with diabetes.
PatientReceived no prior treatments

How responsive is this trial?

Average response time
  • < 2 Days
Typically responds via
Phone Call
Most responsive sites:
  1. Department of Nutrition Sciences, University of Alabamam at Birmingham: < 48 hours
~4 spots leftby Apr 2025